Genome & Company Market Cap

Genome & Company has a market cap or net worth of 73.05 billion as of April 1, 2025. Its market cap has decreased by -45.61% in one year.

Market Cap

73.05B

Enterprise Value

75.78B

Revenue

27.74B

Ranking

n/a

PE Ratio

n/a

Stock Price

2,205.00

Market Cap Chart

Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 73.05B, an increase of 1.63%. That is a compound annual growth rate of 0.26%.

Market Cap History

Date	Market Cap	% Change
Mar 31, 2025	68.54B	-19.56%
Dec 30, 2024	85.21B	-51.64%
Dec 28, 2023	176.21B	-28.34%
Dec 29, 2022	245.90B	-47.55%
Dec 30, 2021	468.83B	-55.28%
Dec 30, 2020	1,048.46B	224.28%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Electronics	396.83T
SK hynix	137.33T
LG Energy Solution	83.30T
Samsung Biologics	74.66T
Hyundai Motor Company	44.69T
Celltrion	38.03T
Kia Corporation	37.52T
KB Financial Group	29.19T

Market Cap Rankings